|
Science
|
Selected Scientific Publications
Ben-Yedidia T.
Hum Vaccin. 2009 Aug;5(8):508-9. Epub 2009 Aug 27.
Y. Adar, Y. Singer, R. Levi, E. Tzehoval, S. Perk, C. Banet-Noach, S. Nagar , R. Arnon, T. Ben-Yedidia.
Vaccine 27 (2009) 2099–2107.
Ben-Yedidia T, Arnon R.
Expert Rev Vaccines. 2007 Dec;6(6):939-48. Review.
Flagella as a platform for epitope-based vaccines
Ben-Yedidia T, Arnon R.
Isr Med Assoc J. 2006 May;8(5):316-8.
Towards an epitope-based human vaccine for influenza
Ben-Yedidia T, Arnon R.
Hum Vaccin. 2005 May-Jun;1(3):95-101. Epub 2005 May 15.
A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin
Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R.
J Biol Chem. 2004 Nov 12;279(46):48410-9. Epub 2004 Sep 8.
Old and new vaccine approaches
Arnon R, Ben-Yedidia T.
Int Immunopharmacol. 2003 Aug; 3(8):1195-204.
A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization
Ben-Yedidia T, Beignon AS, Partidos CD, Muller S, Arnon R.
Mol Immunol. 2002 Oct;39(5-6):323-31.
Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus
Jeon SH, Ben-Yedidia T, Arnon R.
Vaccine. 2002 Jun 21;20(21-22):2772-80.
Peptide-based synthetic recombinant vaccines with anti-viral efficacy
Arnon R, Tarrab-Hazdai R, Ben-Yedidia T.
Biologicals. 2001 Sep-Dec;29(3-4):237-42.
Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni
Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R.
Infect Immun. 1999 Sep;67(9):4360-6.
Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
Ben-Yedidia T, Marcus H, Reisner Y, Arnon R.
Int Immunol. 1999 Jul;11(7):1043-51.
Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine
Ben-Yedidia T, Arnon R.
Immunol Lett. 1998 Nov;64(1):9-15.
Efficacy of anti-influenza peptide vaccine in aged mice
Ben-Yedidia T, Abel L, Arnon R, Globerson A.
Mech Ageing Dev. 1998 Aug 1;104(1):11-23.
Design of peptide and polypeptide vaccines
Ben-Yedidia T, Arnon R.
Curr Opin Biotechnol. 1997 Aug;8(4):442-8.
Synthetic recombinant vaccine induces anti-influenza long-term immunity and cross-strain protection
Arnon R, Levi R.
Adv Exp Med Biol. 1996;397:23-9.
|
